Longevity Today
Sign In

Results for "Partial Epigenetic Reprogramming"

2 articles

All TopicsCancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced TherapiesSleep & Mindfulness
📋All Types🔬Papers📖Reviews▶️Videos🎙️Podcasts🧪Trials💊Approvals📰Press Releases📚Tutorials🎬Animations
Partial Reprogramming Resets Eye Cell Epigenetic Clocks in Living Humans
Regenerative Medicine

Partial Reprogramming Resets Eye Cell Epigenetic Clocks in Living Humans

Activating three Yamanaka factors — OCT4, SOX2, and KLF4 — appears to reverse epigenetic aging in human eye cells, marking a milestone in rejuvenation medicine.

Press Release
Apr 19, 2026 0
Life Biosciences Raises $80M to Advance Epigenetic Reprogramming Therapy
Longevity & Aging

Life Biosciences Raises $80M to Advance Epigenetic Reprogramming Therapy

Boston biotech secures major funding to complete Phase 1 trials of ER-100, a therapy targeting aging through epigenetic reprogramming.

Press Release
Apr 10, 2026 0